Hepatic myelopathy after transjugular intrahepatic portosystemic shunt

来源 :2016第十二届亚太介入放射学大会 | 被引量 : 0次 | 上传用户:yyp0000
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Aim:To explore the pathogenesis of Hepatic myelopathy(HM)after transjugular intrahepatic portosystemic shunt(TIPS).
其他文献
会议
会议
会议
会议
会议
Purpose:To evaluate percutaneous endovascular embolization(EVE)for the management of anomalous systemic arterial(ASA)supply to normal basal segments of the lung.
Objectives:1.To illustrate with case examples the vascular complications of pancreatitis.
Aims:To evaluate the safety and efficacy of placement of totally implantable venous access port using ultrasound guidance and micro-puncture technique at one institution in China.
Objective:To investigate the safety and efficacy of balloon-assisted transcather chemoembolization(TACE)for the treatment of hepatocellular carcinoma(HCC)patients with hepatic artery to portal vein fi
Objective:To examine the safety and short-term efficacy of irreversible electroporation(IRE)ablation in unresectable pancreatic cancer.